• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Correlations between the patient's genotype and the course of the disease in hereditary cancer diseases].

作者信息

Bisgaard Marie Luise

机构信息

Københavns Universitet, Institut for Medicinsk Biokemi og Genetik, Klinik for Medicinsk Genetik, Panum Instituttet 24.4, Blegdamsvej 3, DK-2200 København N.

出版信息

Ugeskr Laeger. 2006 Jun 12;168(24):2341-4.

PMID:16822416
Abstract

The majority of hereditary cancers demonstrate extended variation of phenotype, not only between families, but also within a particular family, who supposedly have inherited the same pathogenic mutation. The present paper reviews genotype-phenotype correlations with examples mainly from the two largest hereditary cancer groups, namely hereditary colorectal cancer and hereditary breast (and ovarian) cancer. It is concluded that knowledge about genotype-phenotype correlations is essential in the cancer genetic clinic; otherwise, the patient tends to base decisions on personal experience, not realising that the course of disease might be different in other family members.

摘要

相似文献

1
[Correlations between the patient's genotype and the course of the disease in hereditary cancer diseases].
Ugeskr Laeger. 2006 Jun 12;168(24):2341-4.
2
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.在西班牙前往遗传咨询机构的BRCA1和BRCA2基因发生突变的携带者患乳腺癌和卵巢癌的平均累积风险。
Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436.
3
[Inherited breast and ovarian cancers].[遗传性乳腺癌和卵巢癌]
Ugeskr Laeger. 2006 Jun 12;168(24):2367-9.
4
Hereditary ovarian cancer.遗传性卵巢癌
Curr Opin Obstet Gynecol. 1997 Feb;9(1):3-7.
5
Screening and prevention of hereditary gynecologic cancers.遗传性妇科癌症的筛查与预防
Semin Oncol. 2007 Oct;34(5):406-10. doi: 10.1053/j.seminoncol.2007.07.004.
6
[Genetic epidemiology of hereditary tumor].[遗传性肿瘤的遗传流行病学]
Nihon Rinsho. 2000 Jul;58(7):1363-9.
7
Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.选择进行BRCA1/2或遗传性非息肉病性结直肠癌(HNPCC)基因易感性检测的个体在应对方式、疾病认知、疾病经历、家庭系统特征和遗传性癌症困扰方面的比较。
Patient Educ Couns. 2007 Jan;65(1):58-68. doi: 10.1016/j.pec.2006.05.006. Epub 2006 Jul 26.
8
[Genetic testing for cancer susceptibility: the present situation in Japan].[癌症易感性的基因检测:日本的现状]
Gan To Kagaku Ryoho. 1997 Jun;24(8):930-7.
9
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.妇科肿瘤学家协会教育委员会关于遗传性妇科癌症易感性风险评估的声明。
Gynecol Oncol. 2007 Nov;107(2):159-62. doi: 10.1016/j.ygyno.2007.09.031.
10
Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.癌症风险评估与遗传咨询过程:以遗传性乳腺癌和卵巢癌为例。
Med Princ Pract. 2008;17(3):173-89. doi: 10.1159/000117790. Epub 2008 Apr 10.